Piezosurgery positive outcomes in orthognatic surgery von Isufi, R.

Volltext

P-66159072-366 - Piezosurgery positive outcomes in orthognatic surgery von Isufi, R.

Volltext

Postlaryngectomy vocal rehabilitation in Albania von Boci, B, Isufi, R, Thomai, K

Volltext

EP1.17-31 30 Days Major Morbidity and Mortality After Lung Cancer Surgery. Outcomes of Five Years in a Single Center Experience von Caushi, F., Xhemalaj, D., Skenduli, I., Bala, S., Isufi, R., Mezini, A., Hafizi, H., Nuredini, O., Hatibi, A., Cani, A.

Volltext

30 Days Major Morbidity and Mortality After Lung Cancer Surgery. Outcomes of Five Years in a Single Center Experience: EP1.17-31 von Caushi, F, Xhemalaj, D, Skenduli, I, Bala, S, Isufi, R, Mezini, A, Hafizi, H, Nuredini, O, Hatibi, A, Cani, A

Volltext

Deep learning methods for flood mapping: a review of existing applications and future research directions von Bentivoglio, Roberto, Isufi, Elvin, Jonkman, Sebastian Nicolaas, Taormina, Riccardo

Volltext

Rapid spatio-temporal flood modelling via hydraulics-based graph neural networks von Bentivoglio, Roberto, Isufi, Elvin, Jonkman, Sebastiaan Nicolas, Taormina, Riccardo

Volltext

Deformation capacity evaluation for flat slab seismic design von Muttoni, A., Coronelli, D., Lamperti Tornaghi, M., Martinelli, L., Pascu, I. R., Pinho Ramos, A., Tsionis, G., Bamonte, P., Isufi, B., Setiawan, A.

Volltext

BISPECIFIC ANTI‐CD20/19 CAR‐T—ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL—INTERIM ANALYSIS RESULTS OF DALY‐II‐USA STUDY von Ulrickson, M., Miklos, D. B., Maziarz, R. T, Jacobson, C., Isufi, I., Ghosh, M., Perales, M., Lunning, M., Hardy, N. M., Wijatyk, A., Ancukiewicz, M., Nallewar, M., Coleman, K. C., Prudner, B. C, Eromosele, E., Kaleta, R., Shah, N. N.

Volltext

Abstract 10039: Rise in Incidence of Takotsubo Syndrome, Associated Comorbidities and Major Adverse Cardiac and Cerebrovascular Events Among Cancer Survivors: A Nationwide Analysis... von Modi, Malak, Bhatt, Nilay R, Jabar Ali, Jamila Begum, Binkam, Mounika, Isufi, Mimoza, yar khan, Nibras, Asfeen, Ummul, Gandhi, Zainab J, Kalolia, Bansari, Desai, Rupak

Volltext

POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL von Bannerji, R., Yuen, S., Phillips, T., Arthur, C., Isufi, I., Marlton, P., Seymour, J. F., Corradini, P., Molinari, A., Gritti, G., Emmons, R., Hirata, J., Musick, L., Saha, S., Croft, B., Flowers, C.

Volltext

Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy von Iqbal, Madiha, Jagadeesh, Deepa, Chavez, Julio, Khurana, Arushi, Rosenthal, Allison, Craver, Emily, Epperla, Narendranath, Li, Zhuo, Isufi, Iris, Awan, Farrukh T., Dholaria, Bhagirathbhai R., Maakaron, Joseph E., Sandoval-Sus, Jose D., Mishra, Rahul, Saha, Aditi, Annunzio, Kaitlin, Bhaskar, Shakthi T., Sumransub, Nuttavut, Fijalka, Andrew, Ivanov, Stanislav A., Lin, Yi, Kharfan-Dabaja, Mohamed A.

Volltext

Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results... von Budde, Lihua E, Sehn, Laurie H, Assouline, Sarit, Flinn, Ian W., Isufi, Iris, Yoon, Sung-Soo, Kim, Won-Seog, Matasar, Matthew J, Nastoupil, Loretta J., Santiago, Raoul, Koh, Youngil, Hernandez, Genevive, Li, Chi-Chung, Kulkarni, Priya R, McCall, Bruce, McClellan, Scott, Yin, Shen, Gupta, Vinita, Chu, Yu-Waye, Bartlett, Nancy L.

Volltext

P1121: TAKEAIM LYMPHOMA‐ AN OPEN‐LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA‐4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOG... von Joffe, E., Nowakowski, G., Tun, H., Rosenthal, A., Lunning, M., Ramchandren, R., Li, C.‐C., Zhou, L., Martinez, E., Roemeling, R., Earhart, R., McMahon, M., Isufi, I., Leslie, L.

Volltext

Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma von Merryman, Reid W, Redd, Robert A., Freedman, Arnold S., Ahn, Inhye E., Brown, Jennifer R., Crombie, Jennifer L., Davids, Matthew S., Fisher, David C., Jacobsen, Eric D, Kim, Austin I., LaCasce, Ann S., Ng, Samuel, Odejide, Oreofe O., Parry, Erin Michelle, Isufi, Iris, Kline, Justin, Cohen, Jonathon B., Mehta-Shah, Neha, Bartlett, Nancy L., Mei, Matthew, Armand, Philippe, Jacobson, Caron A.

Volltext

Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma von Nastoupil, Loretta J., Kuruvilla, John, Chavez, Julio C., Bijou, Fontanet, Witzig, Thomas E., Santoro, Armando, Flinn, Ian W., Boccomini, Carola, Kenkre, Vaishalee P., Corradini, Paolo, Isufi, Iris, Andorsky, David J., Klein, Leonard M., Greenwald, Daniel R., Sangha, Randeep, Shen, Frank, Hagner, Patrick, Li, Yan, Dobmeyer, Juergen, Gong, Nian, Uttamsingh, Shailaja, Pourdehnad, Michael, Ribrag, Vincent

Volltext

A Once Daily, Oral, Triple Combination of BTK Inhibitor, mTOR Inhibitor and IMiD for Treatment of Relapsed/Refractory Richter's Transformation and De Novo Diffuse Large B-Cell Lymp... von Mato, Anthony R., Schuster, Stephen J., Foss, Francine M., Isufi, Iris, Kothari, Shalin K., Ding, Wei, Brander, Danielle M., Sitlinger, Andrea, Rosenthal, Allison C., Leis, Jose F., Tun, Han W., Kennard, Kaitlin, Nelson, Allison R., Falco, Victoria, Komari, Celina J., Koehler, Amber B., Stowe, Rachel, He, Wei, Kearney, Albert, Gui, Min, McKinlay, Tim, Roeker, Lindsey E, Thompson, Meghan C., Huntington, Scott F.

Volltext

Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma von Ribrag, Vincent, Chavez, Julio C., Boccomini, Carola, Kaplan, Jason, Chandler, Jason C., Santoro, Armando, Corradini, Paolo, Flinn, Ian W., Advani, Ranjana, Cassier, Philippe A., Sangha, Randeep, Kenkre, Vaishalee P., Isufi, Iris, Uttamsingh, Shailaja, Hagner, Patrick R., Gandhi, Anita K., Shen, Frank, Michelliza, Sophie, Haeske, Harald, Hege, Kristen, Pourdehnad, Michael, Kuruvilla, John

Volltext

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma von Merryman, Reid W., Redd, Robert A., Freedman, Arnold S., Ahn, Inhye E., Brown, Jennifer R., Crombie, Jennifer L., Davids, Matthew S., Fisher, David C., Jacobsen, Eric D., Kim, Austin I., LaCasce, Ann S., Ng, Samuel, Odejide, Oreofe O., Parry, Erin M., Isufi, Iris, Kline, Justin, Cohen, Jonathon B., Mehta-Shah, Neha, Bartlett, Nancy L., Mei, Matthew, Kuntz, Thomas M., Wolff, Jacquelyn, Rodig, Scott J., Armand, Philippe, Jacobson, Caron A.

Volltext

A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalidomide in Pati... von Mato, Anthony R., Schuster, Stephen J, Foss, Francine M., Isufi, Iris, Ding, Wei, Brander, Danielle M., Sitlinger, Andrea, Tun, Han W., Alhaj Moustafa, Muhamad, Kennard, Kaitlin, King, Cara M, Koehler, Amber, Aitken, Casey, He, Wei, Kearney, Albert, Gui, Min, Anderson, Barry Douglas, Rosenthal, Allison C., Roeker, Lindsey E., Huntington, Scott F.

Volltext